- Accueil
- Congrès
- JESFC 2023
- Hub 1 16:00:00 Traitement, prise en charge
Traitement, prise en charge
Mercredi
11
Janvier 2023
16:00-17:00
Hub 1
JESFC 2023 |
Présentation flash
Modérateur(s) : Corentin BOURG, François PICARD
Orateur(s) : Messaouda DJOUHRI, Laetitia POURTAU, Nicolas CHAPET, Jeremy MAROT, Hinda ALLAOUI, Hanae CHARIF, Nabila TALEB BENDIAB, Liane BOURCIER, Chris Nadège NGANOU-GNINDJIO, Guillaume COUTANCE, Tatiana HERTZOG
16:00
•
Messaouda Djouhri
Impact of therapeutic optimization and prevalence of reverse remodeling in heart failure with reduced ejection fraction. About a series of 252 patients
Voir la présentation
16:05
•
Laetitia Pourtau
Prevalence, management and outcomes of haemorrhagic events in left ventricular assist device recipients
Voir la présentation
16:10
•
Nicolas Chapet
Evaluation of factors influencing immunosuppressant adherence among heart transplant patients: FIAHT study
16:15
•
Jeremy Marot
Description of the care pathway for patients hospitalized for acute heart failure (AHF)
Voir la présentation
16:20
•
Hinda Allaoui
In silico approaches for the design of a novel analog of lebetin 2, has a better effect on the molecular mechanism of action in ischemia cardiology
16:25
•
Hanae Charif
The consequences of confinement on patients followed at the heart failure treatment unit (UTIC): experience of the cardiology department – ?€‹?€‹CHU Ibn rochd-Casablanca
16:30
•
Nabila Taleb Bendiab
Impact of SGLT2 inhibitors on the evolution of echocardiographic parameters of patients with chronic heart failure
Voir la présentation
16:35
•
Liane Bourcier
Effects of COLchicine on inflammation, myocardial damage and microvascular dysfunction in heart failure with Preserved Ejection Fraction – The COLpEF trial
Voir la présentation
16:40
•
Chris Nadège Nganou-Gnindjio
The short-term effect of parenteral iron supplementation on oxidative status in patients with chronic heart failure and iron deficiency: a sub analysis of the ERADAL-HF study
16:45
•
Guillaume Coutance
Application of the new cardiac allograft allocation scheme in clinical practice. Insights from a high-volume heart transplantation center
Voir la présentation
16:50
•
Tatiana Hertzog
Prevalence of early and late left ventricular reverse remodeling in dilated cardiomyopathy under optimal medical therapy
Voir la présentation
